Hyphens Pharma International Limited (SGX:1J5)

SGXC:1J5 Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	18.79	23.42	23.37	36.48	19.46	27.53
Cash & Short-Term Investments	18.79	23.42	23.37	36.48	19.46	27.53
Cash Growth	4.81%	0.22%	-35.94%	87.45%	-29.30%	5.20%
Accounts Receivable	41.2	43.16	39.63	30.12	27.82	22.83
Other Receivables	2.12	1.56	0.75	0.39	0.3	0.4
Receivables	43.32	44.71	40.38	30.51	28.12	23.23
Inventory	26.31	34.45	25.53	21.26	25.29	16.89
Prepaid Expenses	3.3	2.53	2.06	0.81	0.64	0.56
Other Current Assets	1.05	0.98	0.82	0.59	0.6	0.51
Total Current Assets	92.77	106.09	92.15	89.65	74.11	68.71
Property, Plant & Equipment	4.23	4.9	4.86	3.02	4.41	4.81
Long-Term Investments	-	-	-	2.67	2.31	-
Goodwill	15.4	15.4	15.4	12.81	12.81	4.85
Other Intangible Assets	8.87	9.13	8.18	6.26	5.49	3.04
Long-Term Deferred Tax Assets	0.12	0.23	0.17	0.06	0.07	0.05
Total Assets	121.38	135.75	120.77	114.47	99.19	81.46
Accounts Payable	38.26	42.3	42.83	34.19	32.42	27.21
Short-Term Debt	-	9.01	-	-	4.24	0.4
Current Portion of Long-Term Debt	9.15	1.25	1.25	1.25	1.83	0.17
Current Portion of Leases	1.33	1.28	1.17	1.09	1.21	0.85
Current Income Taxes Payable	2.71	2.58	2.54	2.66	1.71	1.35
Other Current Liabilities	-	1.27	1.46	0.88	1.15	0.34
Total Current Liabilities	51.46	57.69	49.24	40.07	42.56	30.32
Long-Term Debt	0.1	0.73	1.98	3.23	-	1.83
Long-Term Leases	1.15	1.84	2.43	0.1	0.88	1.73
Long-Term Deferred Tax Liabilities	0.94	1.02	1.25	0.79	1.02	0.41
Total Liabilities	53.66	61.28	54.9	44.2	44.46	34.28
Common Stock	35.22	35.22	35.22	35.08	35.08	32.64
Retained Earnings	39.34	45.23	37.77	43.76	34.61	29.63
Treasury Stock	-0.09	-0.09	-	-	-	-
Comprehensive Income & Other	-9.24	-9.46	-10	-9.82	-14.96	-15.09
Total Common Equity	65.23	70.9	62.99	69.03	54.74	47.18
Minority Interest	2.5	3.57	2.88	1.25	-	-
Shareholders' Equity	67.72	74.47	65.86	70.27	54.74	47.18
Total Liabilities & Equity	121.38	135.75	120.77	114.47	99.19	81.46
Total Debt	11.74	14.11	6.82	5.67	8.17	4.97
Net Cash (Debt)	7.05	9.31	16.55	30.81	11.29	22.55
Net Cash Growth	-31.11%	-43.76%	-46.29%	172.85%	-49.93%	-0.50%
Net Cash Per Share	0.02	0.03	0.05	0.10	0.04	0.08
Filing Date Shares Outstanding	308.88	308.88	309.2	308.78	308.78	300.43
Total Common Shares Outstanding	308.88	308.88	309.2	308.78	308.78	300.43
Working Capital	41.31	48.4	42.91	49.58	31.56	38.4
Book Value Per Share	0.21	0.23	0.20	0.22	0.18	0.16
Tangible Book Value	40.96	46.37	39.41	49.96	36.44	39.29
Tangible Book Value Per Share	0.13	0.15	0.13	0.16	0.12	0.13
Machinery	12.14	11.99	10.64	10.81	10.28	9.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.